Bayer: all 1,694 studies
Page 11 of 17. Open to participants first (61), then studies with results posted, then the rest; newest registration first within each.
- Special Drug Use Investigation of EYLEA for Diabetic Macular EdemaCompletedNCT02425501
- To Evaluate Effectiveness of Visanne in Improving Quality of Life in Asian Women With EndometriosisCompletedNCT02425462
- Duration of Use of Highly Effective Reversible ContraceptionCompletedNCT02414919
- Blood Pressure Control of Nifedipine GITS 60mg Treatment in Chinese Hypertensive Subjects Uncontrolled on Starting-dose Mono-therapyo-therapy.CompletedNCT02413515Phase 4
- Risk Minimisation Study for Diane-35 and Its GenericsCompletedNCT02410031
- Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy WomenCompletedNCT02403401Phase 3
- Pain Evaluation in Radium-223 Treated Castration Resistant Prostate Cancer Patients With Bone MetastasesCompletedNCT02398526
- Regorafenib Phase I Study in Mainland Chinese PatientsCompletedNCT02398513Phase 1
- Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its TreatmentCompletedNCT02396862
- To Evaluate the Bioavailability of a Single Oral Dose of the Acetylsalicylic Acid Containing Dry Powder 500 mg in Comparison to the Bioavailability of a Single Oral Dose of Aspirin Tablets and Aspirin Effervescent Tablets in Healthy Adults.CompletedNCT02394093Phase 1
- Roniciclib Mass Balance StudyCompletedNCT02390154Phase 1
- BAY1238097, First in ManTerminatedNCT02369029Phase 1
- Phase I, Dose-escalation Trial of BAY1187982 in Subjects With Advanced Solid Tumors Known to Express Fibroblast Growth Factor Receptor 2 (FGFR2)TerminatedNCT02368951Phase 1
- Relative Bioavailability Study in Healthy Subjects Comparing 2 Dry Powder Oral Suspensions of Rivaroxaban Under Fasting and 20 mg of an Oral Suspension of Rivaroxaban Under Fed Conditions to 10 mg of an Immediate Release Tablet Under Fasting ConditionsCompletedNCT02367027Phase 1
- Phase I Study of Oral BAY 1217389 in Combination With Intravenous PaclitaxelCompletedNCT02366949Phase 1
- Phase 1 Dose Escalation Study of BAY 1841788 in Japanese Metastatic Castration-resistant Prostate Cancer (mCRPC) SubjectsCompletedNCT02363855Phase 1
- JAYDESS Drug Utilization Study in SwedenCompletedNCT02349815
- Drug Utilization Study on Diane-35 (and Generics) in Three European Healthcare DatabasesCompletedNCT02349399
- Assessment of Physical Activity During Therapy With Regorafenib for Metastatic Colorectal CancerCompletedNCT02347852
- Phase I Dose Escalation of BAY1143572 in Subjects With Acute LeukemiaCompletedNCT02345382Phase 1
- Japanese Phase Ib/II Copanlisib in Relapsed, Indolent B-cell NHLCompletedNCT02342665Phase 1/2
- Sorafenib Drug Drug Interaction Study in Healthy Male SubjectsCompletedNCT02332031Phase 1
- A Drug Utilization Study of Radium-223 in SwedenCompletedNCT02331303
- Real Life of Aflibercept in France in Patients Refractory to Ranibizumab: Observational Study in Wet AMDCompletedNCT02321241
- 2-cohort Study of Adult Patients With Severe Hemophilia A in GreeceCompletedNCT02319070
- To Investigate Pharmacokinetics (Absorption, Distribution, Elimination), Safety and Tolerability of a Single Oral Dose of 75 mg Molidustat Tablet in Male and Female Subjects Requiring Hemo- or Peritoneal Dialysis Compared to Healthy SubjectsCompletedNCT02312973Phase 1
- An Observational Study in Differentiated Thyroid Cancer Which is Radioactive Iodine (RAI) Refractory to Assess the Use of Multikinase InhibitorsCompletedNCT02303444
- Efficacy and Safety of Polyethylene Glycol 3350 (PEG 3350) for Relief of Constipation (MK-8114-005)WithdrawnNCT02292459Phase 3
- Aflibercept (Eylea) in roUtine Clinical Practice in patientS With Wet Age-related Macular Degeneration in ItalyCompletedNCT02289924
- Colorado Adult Joint Assessment Scale (CAJAS) ValidationCompletedNCT02284789Not applicable
- Real Life of Aflibercept In FraNce: oBservatiOnnal Study in Wet AMDCompletedNCT02279537
- Retrospective Study in Chinese Pediatric Hemophilia A Patients With rFⅧ Contained Regular ProphylaxisCompletedNCT02263066
- Observational Study to Assess Sociodemographic and Clinical Features of Patients Treated With Rivaroxaban in Routine Clinical Practice of Hematologists, Cardiologists and Internists of SpainCompletedNCT02262676
- Study in Healthy Young Women to Investigate the Pharmacodynamics, Pharmacokinetics and Safety of VilaprisanCompletedNCT02262663Phase 1
- Special Drug Use Investigation of EYLEA for Myopic Choroidal NeovascularizationCompletedNCT02260687
- COPANLISIB (BAY80-6946) Drug-drug Interaction and Cardiovascular Safety Study in Advanced Solid Tumor and Non-Hodgkin's Lymphoma PatientsCompletedNCT02253420Phase 1
- BETAEVAL Global - The New BETACONNECT Auto-injector : Adherence and EVALuation of Multiple Sclerosis Patients Treated With BetaferonCompletedNCT02247310
- Efficacy/Safety Pilot Study to Investigate Iberogast N's Efficacy in Mild to Moderate Colitis Ulcerosa PatientsTerminatedNCT02246686Phase 2
- First in Human Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of BAY1214784CompletedNCT02212080Phase 1
- Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care TherapyCompletedNCT02210819
- Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With SorafenibActive, not recruitingNCT02185560
- Clinical Study Investigating the Conversion of the Contraceptive Compound Norethisterone Within the Body Towards the Contraceptive Compound EthinylestradiolCompletedNCT02170038Phase 1
- RONICICLIB / Placebo in Combination With Chemotherapy in Small Cell Lung CancerTerminatedNCT02161419Phase 2
- Microgynon Riociguat Drug Interaction Study in Healthy Postmenopausal WomenCompletedNCT02159326Phase 1
- Relative Bioavailability StudyCompletedNCT02159313Phase 1
- Assess Satisfaction of Patients and Physicians With Results of Yaz Plus Treatment for 13 CyclesCompletedNCT02159261
- Copanlisib Pharmacodynamic StudyCompletedNCT02155582Phase 1
- Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous PaclitaxelTerminatedNCT02138812Phase 1
- Dose-escalation Study of Lupartumab Amadotin (BAY1129980)TerminatedNCT02134197Phase 1
- A Study to Test the Safety of the Investigational Drug Larotrectinib in Adults That May Treat CancerCompletedNCT02122913Phase 1
- BAY86-5046 (Betaseron), Non Interventional StudiesCompletedNCT02121444
- Copanlisib Mass Balance StudyCompletedNCT02119221Phase 1
- Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Riociguat for Chronic Thromboembolic Pulmonary Hypertension (CTEPH )CompletedNCT02117791
- Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma PatientsCompletedNCT02114658Phase 2
- Stivarga Regulatory Post-Marketing Surveillance Study in KoreaCompletedNCT02106858
- Effect of Regorafenib on Digoxin and Rosuvastatin in Patients With Advanced Solid Malignant Tumors.CompletedNCT02106845Phase 1
- EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary HypertensionCompletedNCT02092818
- BAY 59-7939 (Xarelto, SPAF), Non Interventional StudiesCompletedNCT02090543
- A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard TherapyCompletedNCT02085148Phase 1
- Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934CompletedNCT02064426Phase 2
- Essure (Model ESS310) Placement Rate StudyCompletedNCT02064413Phase 3
- Cardiovascular Disease Risk Factors Prevalence Among Bayer's Employees in São Paulo, BrazilCompletedNCT02055651
- Long-term Pre-dialysis Extension in Europe and Asia PacificCompletedNCT02055482Phase 2
- Japanese BAY1000394 Monotherapy Phase I StudyCompletedNCT02047890Phase 1
- Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan CilexetilWithdrawnNCT02047019Phase 3
- Safety and Effectiveness of RegorafenibCompletedNCT02042144
- Multiple Dose Study in Heart Failure of BAY 1067197CompletedNCT02040233Phase 2
- Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Eylea for Central Retinal Vein Occlusion (CRVO)CompletedNCT02040220
- Comparative PK PD Study in PAH Patients (Fox vs. I-Neb)CompletedNCT02032836Phase 1/2
- Maintenance Treatment of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease on Darbepoetin Treatment Versus BAY85-3934CompletedNCT02021409Phase 2
- 15141 Fixed Dose Correction / naïve and Pre Dialysis (Europe and Asia Pacific)CompletedNCT02021370Phase 2
- Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 InhibitorCompletedNCT02007629Phase 3
- Effect of Neomycin on the Pharmacokinetics of RegorafenibCompletedNCT02001909Phase 1
- Sorafenib as Neoadjuvant Therapy Before Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell CarcinomaCompletedNCT01982097
- Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934CompletedNCT01975818Phase 2
- Safety and Pharmacokinetics of Regorafenib and Cetuximab in CombinationCompletedNCT01973868Phase 1
- Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary HypertensionCompletedNCT01971450
- Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)CompletedNCT01968668Phase 2
- Study to Assess the Dietary Carbohydrate Content of Indian Diabetics With Special Therapeutic View on Effectiveness of Acarbose and Metformin MonotherapyWithdrawnNCT01961388
- MIRENA for Contraception In InDian Subjects User continuAtion and Satisfaction Study: MIDAS StudyCompletedNCT01961375
- Investigating the Use of Regorafenib (Stivarga®) in Patients With Metastatic Colorectal Cancer (mCRC) After Failure of Standard TherapyCompletedNCT01959269
- Bleeding Pattern Difference Between Levonorgestrel Intrauterine System (LNG-IUS) and Copper Intrauterine Devices (IUDs) Immediately Inserted After AbortionCompletedNCT01958684
- Fosrenol Post-marketing Surveillance in JapanCompletedNCT01955876
- Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Disease AloneCompletedNCT01955694Phase 2
- Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in WomenCompletedNCT01948882Not applicable
- Efficacy/Safety Study to Explore a New Revised Topical Formulation in Atopic DermatitisCompletedNCT01948869Not applicable
- Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)CompletedNCT01947998
- Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)CompletedNCT01947985
- Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)CompletedNCT01947959
- Study to Assess the Safety of BAY1067197 in Stable Heart Failure Patients on Standard Therapy Including ß-blockerCompletedNCT01945606Phase 2
- Efficacy/Safety Study to Confirm Iberogast's Efficacy in Patients With Irritable Bowel Syndrome Diagnosed on ROME III Criteria Compared to PlaceboCompletedNCT01940848Phase 3
- Open Label Phase I Dose Escalation Study With BAY1143572 in Patients With Advanced CancerCompletedNCT01938638Phase 1
- Regorafenib Post-marketing Surveillance in JapanCompletedNCT01933958
- Outcomes of HCC (Hepatocellular Carcinoma) Patients Treated With TACE (Transarterial Chemoembolization) and Early, Not Early or Not at All Followed by SorafenibCompletedNCT01933945
- Study to Assess the EffectiVeness of exIsting Anti-vascular Endothelial groWth Factor (Anti-VEGF) Treatment Regimens in Patients With Wet Age-related Macular DegenerationCompletedNCT01933152
- Japanese BAY88-8223 Monotherapy Phase II StudyCompletedNCT01929655Phase 2
- Retrospective Registry Providing Baseline Data on the Outcome of Left Atrial (LA) or LA Appendage (LAA) Thrombus in Patients With Nonvalvular Atrial Fibrillation (AF) or Atrial Flutter After Standard of Care (SoC) Anticoagulant TherapyCompletedNCT01928979
- Placebo Controlled Phase IV Study to Compare the Efficacy and Safety of a Single Dose of Oral Talcid, a Single Dose of Oral Famotidine and a Single Dose of Placebo in Patients With Acute Heartburn EpisodesCompletedNCT01928888Phase 4
- Study to Assess Bioequivalence of 30 and 120 mg Nifurtimox Tablets in Chronic Chagas' PatientsCompletedNCT01927224Phase 1
- Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) StimulatorCompletedNCT01926847Phase 2